Sign in

Mark Schuster

Vice President and Equity Research Analyst at William Blair Investment Management, LLC

Mark Schuster is a Vice President and Equity Research Analyst at William Blair, specializing in the coverage of healthcare services and technology companies. He covers several notable firms in the healthcare sector, delivering investment research and recommendations based on rigorous financial analysis, though specific performance metrics such as success rate or returns generated are not publicly available. Schuster began his career in financial analysis prior to joining William Blair in the early 2020s, and his prior experience includes roles in related finance and research functions, helping build expertise in the healthcare landscape. He holds professional securities licenses as part of his FINRA registration, supporting his role as a licensed research analyst.

Mark Schuster's questions to Enovix (ENVX) leadership

Question · Q2 2025

Asked about expected Average Selling Prices (ASPs) for high-capacity smartphone batteries and the company's pricing power, as well as the market dynamics and technical advantages for Enovix in the AR/smart glass sector.

Answer

The company expects ASPs to rise as battery capacity increases across all phone tiers, and their unique high-density AI1 battery should command a premium. For AR glasses, the need for high power in a small, custom form factor with good thermal performance makes Enovix's technology a strong fit, justifying higher margins.

Ask follow-up questions

Fintool

Fintool can predict Enovix logo ENVX's earnings beat/miss a week before the call

Let Fintool AI Agent track Mark Schuster for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free